Picture of VIVA Biotech Holdings logo

1873 VIVA Biotech Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSuper Stock

Annual cashflow statement for VIVA Biotech Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-356348-459-56296
Depreciation
Amortisation
Non-Cash Items409-116758277-23.5
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-90.9-307-98.4-48.9-112
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities32.277.8386383374
Capital Expenditures-593-565-250-188-192
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-3,246-304-123627378
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-3,838-869-373439186
Financing Cash Flow Items-17.3-84.3-70.6410-14.2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5,307-653-143-430-658
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,404-1,508-122358-94.6